c
x
chart
exchange
Terminal
Flow
Screener
Markets
Trends
Premium
Alerts
EDT
UTC-4 New York
Blue Chip
Log in
Sign up
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
stock
NASDAQ
Market Open
Oct 5, 2026 1:24:17 PM EDT
7.70
USD
+6.354%
(+0.46)
696,749
7.6700
Bid
7.7000
Ask
0.0300
Spread
Pre-market
After-hours
Overview
Historical
Exchanges
Shorts
News
News
EPRX News
1
/
1
Sep 30, 2026
Day breaks
Sep 30, 2026
08:13 AM EDT
Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis
·
Financial Post
08:00 AM EDT
Eupraxia Pharmaceuticals Reports 52-Week Data from the Highest Dose Cohort of EP-104GI in its Ongoing Phase 1b/2a RESOLVE Trial for the Treatment of Eosinophilic Esophagitis
·
GlobeNewswire Inc.
Sep 24, 2026
07:38 AM EDT
Wedbush initiates Eupraxia Pharmaceuticals stock with Outperform rating
·
Investing.com